Factors associated with active tuberculosis in Colombian patients with systemic lupus erythematosus: a case-control study

作者: Luis Alonso González-Naranjo , Jaime Alberto Coral-Enríquez , Mauricio Restrepo-Escobar , Carlos Horacio Muñoz-Vahos , Daniel Jaramillo-Arroyave

DOI: 10.1007/S10067-020-05225-X

关键词:

摘要: To identify factors associated with active tuberculosis (TB) in patients systemic lupus erythematosus (SLE). We performed a retrospective case-control study two tertiary care teaching hospitals Medellin, Colombia. From January 2007 to December 2017, total of 268 SLE were included. TB (cases) matched 1:3 without (controls) by disease duration and the date hospitalization which diagnosis was made (index cases) nearest available rheumatology controls (± 2 years). Conditional univariable multivariable logistic regression analyses performed. Sixty-seven cases 201 assessed. Only pulmonary occurred 46.3%, only extrapulmonary 16.4% disseminated 37.3% cases. Multivariable analysis showed that lymphopenia (OR, 2.91; 95% CI 1.41–6.03; P = 0.004), 12-month cumulative glucocorticoid dose ≥ 1830 mg 2.74; 1.26–5.98; P = 0.011), having been treated ≥ 2 immunosuppressants during last 12 months 2.81; 1.16–6.82; P = 0.022) after adjusting for age, sex, ethnicity, duration, activity, comorbidity index. A trend towards an association kidney transplantation also found 3.77; 0.99–14.30; P = 0.051). Among patients, dose, lymphopenia, use infection.

参考文章(43)
Yoo Dh, Bae Sc, Jun Jb, Yun Je, Kim Ty, Jung S, Kim Th, Lee Sw, The incidence and clinical characteristics of Mycobacterium tuberculosis infection among systemic lupus erythematosus and rheumatoid arthritis patients in Korea. Clinical and Experimental Rheumatology. ,vol. 20, pp. 127- 132 ,(2002)
Luis Alberto Ramírez Gómez, Juan Fernando Velásquez, Paula Granda, Carlos Alfonzo Builes, Fabián Jaimes, None, Asociación de actividad lúpica y el riesgo de infección nosocomial en pacientes de un Hospital universitario en Medellín: estudio prospectivo 2001-2004 Revista Colombiana de Reumatología. ,vol. 14, pp. 177- 186 ,(2007)
Mo Yin Mok, Yi Lo, Tak Mao Chan, Woon Sing Wong, Chak Sing Lau, None, Tuberculosis in systemic lupus erythematosus in an endemic area and the role of isoniazid prophylaxis during corticosteroid therapy. The Journal of Rheumatology. ,vol. 32, pp. 609- 615 ,(2005)
Bernardo A. Pons-Estel, Luis J. Catoggio, Mario H. Cardiel, Enrique R. Soriano, Silvana Gentiletti, Antonio R. Villa, Isaac Abadi, Francisco Caeiro, Alejandro Alvarellos, Donato Alarcón-Segovia, The GLADEL multinational Latin American prospective inception cohort of 1,214 patients with systemic lupus erythematosus: ethnic and disease heterogeneity among "Hispanics". Medicine. ,vol. 83, pp. 1- 17 ,(2004) , 10.1097/01.MD.0000104742.42401.E2
Luis M. Vilá, Graciela S. Alarcón, Gerald McGwin, Holly M. Bastian, Barri J. Fessler, John D. Reveille, , Systemic lupus erythematosus in a multiethnic US cohort, XXXVII: Association of lymphopenia with clinical manifestations, serologic abnormalities, disease activity, and damage accrual Arthritis Care and Research. ,vol. 55, pp. 799- 806 ,(2006) , 10.1002/ART.22224
J-G Erdozain, G Ruiz-Irastorza, M-V Egurbide, A Martinez-Berriotxoa, C Aguirre, High risk of tuberculosis in systemic lupus erythematosus Lupus. ,vol. 15, pp. 232- 235 ,(2006) , 10.1191/0961203306LU2289XX
Gisele Zandman-Goddard, Yehuda Shoenfeld, Gisele Zandman-Goddard, Yehuda Shoenfeld, Infections and SLE Autoimmunity. ,vol. 38, pp. 473- 485 ,(2005) , 10.1080/08916930500285352
Petar Lenert, Gordana Lenert, Jean-Luc Senécal, CD4-reactive antibodies in systemic lupus erythematosus. Human Immunology. ,vol. 49, pp. 38- 48 ,(1996) , 10.1016/0198-8859(96)00058-4
DAVID B. HELLMANN, MICHELLE PETRI, QUINN WHITING-OʼKEEFE, Fatal infections in systemic lupus erythematosus: the role of opportunistic organisms. Medicine. ,vol. 66, pp. 341- 348 ,(1987) , 10.1097/00005792-198709000-00002
Mary E. Charlson, Peter Pompei, Kathy L. Ales, C.Ronald MacKenzie, A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation☆ Journal of Chronic Diseases. ,vol. 40, pp. 373- 383 ,(1987) , 10.1016/0021-9681(87)90171-8